we suggest that intestinal imidopeptide hydrolase activities , such as ( a ) and ( b ) , are sensitive to changes in intestinal disease generally , particularly to the altered physiology associated with flattening of the mucosa , and are secondary to , rather than a cause of , the intestinal pathology .
C0021831
intestinal disease
C0021853
intestinal